About us

At Temisis, we are profoundly passionate about innovation,
and we want it to make a difference in people’s lives.

Temisis was created in December 2017 in Nancy, France, based on the discovery of original compounds with remarkable anti-inflammatory properties. The compounds are fighting auto-immune mechanism and their structure is patented worldwide. The originality of these New Chemical Entities (NCEs) requires dedicated production solutions that are currently being developed in order to generate pharmacy-grade batches.

Our ambition is nothing less than to create safe new drugs with outstanding efficacy that fulfill patients’ needs. We are determined to achieve this highly challenging objective using a new perspective on drug discovery. Thanks to a new approach, we generate more drug candidates, creating more possibilities, paving the way for successful drug development.

X